Azoline: More from Barrier Therapeutics
I just spoke with the public relations department at BT this morning.
They said that their Phase IIB dose-ranging trials will begin in the
United States in late 2005. If everything goes well, they expect to
begin their long-range Phase III trials in 2007. Azoline could be
approved as early as 2008.
Their ketoconazole gel, Sebazole, has completed all trials and should
be available in 2006.
Their also working on Hyphanox, which is a once per day tablet form
of itraconazole.
The woman I spoke with suggested I speak with the company’s head of
marketing. So, if you have any questions you would like me to ask
him, I will do so and print a transcript of our conversation.
I suggested that if they are looking for subjects for their trials,
we have a group of 300+ from all around the country who would
probably be willing to participate.
Thanks,
Tim